Rodríguez de Córdoba, S and Goicoechea de Jorge, E
[2007]. Predisposición genética al síndrome hemolítico urémico atípico. Avances en la elucidación de mecanismos patogénicos y su relevancia en el desarrollo de estrategias terapéuticas. FMC Nefrología e Hipertensión 3(9):8-21.
Mollnes TE, Jokiranta TS, Truedsson L, Nilsson B, Rodríguez de Córdoba S, Kirschfink M.
[2007]. Complement analysis in the 21st century. Mol Immunol 44:3838-49.
Vilchez D, Ros S, Cifuentes D, Pujadas Ll, Vallés J, García-Fojeda B, Criado-García O, Fernández-Sánchez E, Medraño MI, Domínguez J, García-Rocha M, Soriano E, Rodríguez de Córdoba S and Guinovart JJ.
[2007]. Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nature Neurosciences 10:1407-13.
Smith RJH, Alexander J, ..., Rodríguez de Córdoba S, ..., Zipfel PF (28 authors).
[2007]. Dense Deposit Disease: New approaches to the treatment of dense deposit disease. J. Am Soc Nephrol. 18:2447-56.
Feito MJ, Sánchez A, Oliver MA, Pérez-Caballero D, Rodríguez de Córdoba S, Albertí S and Rojo JM.
[2007]. Membrane Cofactor Protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: Binding to M type 18 strains is independient of Emm or Enn proteins. Mol Immunol. 44:3571-9
Enriquez JA, Moreno-Loshuertos R, Acin-Perez R, Movilla N, Gallardo ME, Rodríguez de Córdoba S, Pérez-Martos A, Fernández-Silva P.
[2007]. Reply to "Reactive oxygen species and the segregation of mtDNA sequence variants. NatGenet 2007 May. 39(5):572
Pickering MC, Goicoechea de Jorge E, Martínez-Barricarte R, Recalde S, García-Layana A, Rose KL, Moss J, Walport MJ, Cook HT, Rodríguez de Córdoba S, Botto M.
[2007]. Spontaneous haemolytic uraemic syndrome triggered by complement factor H lacking surface recognition domains. J Exp Med. 204:1249-56
Gómez-Garre P,Gutiérrez-Delicado E, Gómez-Abad C, Morales-Corraliza J, Villanueva VE, Rodríguez de Córdoba S, Larrauri J, Gutiérrez M, Berciano J and Serratosa JM.
[2007]. Hepatic disease as the first manifestation of progressive myoclonus epilepsy of Lafora. Neurology. 68:1369-73
Goicoechea de Jorge E, Harris CL, Esparza-Gordillo J, Carreras L, Aller Arranz E, Abarrategui Garrido C, López-Trascasa M, Sánchez-Corral P, Morgan BP and Rodríguez de Córdoba S.
[2007]. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc Natl Acad Sci U S A. 104:240-245
Saunders RE, Frémeaux-Bacchi V, Goicoechea de Jorge E, Goodship THJ, López Trascasa M, Noris M, Ponce Castro IM, Remuzzi G, Rodriguez de Cordoba S, Sanchez-Corral P and Perkins SJ.
[2007]. The interactive Factor H - aHUS mutation database and website: Update and integration of MCP and FI mutations with structural models. Human Mutation 28:222-234
Moreno-Loshuertos R, Acin-Perez R, Fernandez-Silva P, Movilla N, Perez-Martos A, Rodriguez de Cordoba S, Gallardo ME, Enriquez JA.
[2006]. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet. Nov;38(11):1261-8.
Gallardo ME, Moreno-Loshuertos R, López C, Casqueiro M, Silva J, Bonilla F, Enríquez JA and Rodríguez de Córdoba S.
[2006]. m.6267G>A, a recurrent mutation in the human mitochondrial DNA that reduces cytochrome c oxidase activity and is associated with tumors. Human Mutation. 27(6):575-82
Sanchez-Pernaute O, Esparza-Gordillo J, Largo R, Calvo E, Alvarez-Soria MA, Marcos ME, Herrero-Beaumont G, Rodriguez de Cordoba S.
[2006]. Expression of the peptide C4b-binding protein {beta} in the arthritic joint. Ann Rheum Dis. 2006 Oct;65(10):1279-85.
Ladjouze-Rezig A, Rodriguez de Cordoba S, Aquaron R.
[2006]. Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families. Joint Bone Spine. 2006 May;73(3):284-92.
Heinen S, Sanchez-Corral P, Jackson MS, Strain L, Goodship JA, Kemp EJ, Skerka C, Jokiranta S, Meyers K, Wagner E, Robitaille P, Esparza-Gordillo J, Rodriguez de Cordoba S, Zipfel PF, Goodship THJ.
[2006]. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Human Mutation 27:292-3
Esparza-Gordillo J, Goicoechea de Jorge E, Abarrategui Garrido C, Carreras L, López-Trascasa M, Sánchez-Corral P and Rodríguez de Córdoba S.
[2006]. Insights into Hemolytic Uremic Syndrome: Segregation of three independent predisposition factors in a large, multiple affected pedigree. Mor Immunol. 43:1769-75
Nierman W, ..., García JL, ..., Peñalva MA, ..., Rodríguez de Córdoba S, ..., Denning DW (89 authors)
[2005]. Genomic sequence of the pathogenic and allergenic Aspergillus fumigatus. Nature 438:1151-1156
Gómez-Abad C, Gómez-Garre P, Gutiérrez-Delicado E, Saygi S, Michelucci R, Tassinari CA, Rodríguez de Córdoba S and Serratosa JM.
[2005]. Lafora Disease due to EPM2B mutations. A clinical and genetic study. Neurology 64:982-986.
Esparza-Gordillo J, Goicoechea de Jorge E, López-Trascasa M, Sánchez-Corral P and Rodríguez de Córdoba S.
[2005]. Predisposition to atypical Hemolytic Uremic Syndrome involves the concurrence of different susceptibility alleles in the Regulators of Complement Activation gene cluster in 1q32. Hum. Mol. Genet. 14:703-712.
Rodríguez de Cordoba S, Esparza Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M and Sánchez-Corral P.
[2004]. The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 41:355-367.
